Alternate statistical tools and limitations in genetic marker association studies in single-arm drug cancer trials

J Clin Oncol. 2008 Mar 20;26(9):1400-1. doi: 10.1200/JCO.2007.14.7306.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / genetics*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Cetuximab
  • Clinical Trials as Topic
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / pathology
  • Data Interpretation, Statistical
  • ErbB Receptors / genetics*
  • Gene Expression Regulation, Neoplastic / genetics
  • Genetic Markers
  • Humans
  • Irinotecan
  • Polymorphism, Genetic*
  • Research Design
  • Salvage Therapy / methods

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • Genetic Markers
  • Irinotecan
  • ErbB Receptors
  • Cetuximab
  • Camptothecin